Radioembolization: Technical Tips and Follow-Up Imaging
Journal of the Korean Society of RadiologyTransarterial radioembolization (TARE) is a minimally invasive treatment modality for hepatocellular carcinoma (HCC) that delivers targeted radiation via radioactive microspheres.
Hyo-Cheol Kim
doaj +1 more source
Einstein (São Paulo)Transarterial selective internal radiation therapy with yttrium-90, also known as radioembolization, is a therapy based on the administration of resin or glass microspheres loaded with the radioisotope yttrium-90, via selective arterial catheterization ...
Breno Boueri Affonso +7 more
doaj +1 more source
TIPS and HCC: friends or foes ? [PDF]
, 2016 Portal hypertension and hepatocellular carcinoma [HCC] are major complications of liver cirrhosis and may coexist in the same patient. Transjugular intrahepatic portosystemic shunt [TIPS] is an effective treatment for recurrent variceal bleeding
DE SANTIS, Adriano
core
03:09 PM Abstract No. 113 Lobar Yttrium-90 transarterial radioembolization equal or greater than 150Gy MIRD: an analysis of hepatic biochemical safety as a function of treated liver volume and administered dose [PDF]
, 2019 Abdelrahman Ahmed +19 more
openalex +1 more source
Transarterial Radioembolization in Patients With Unresectable Colorectal Cancer Liver Metastases [PDF]
Journal of Clinical Oncology, 2021 Robert W. Lentz, Wells A. Messersmith
openaire +2 more sources
Role of Transarterial Radioembolization in Management of HCC
Transarterial Radioembolization (TARE) is an emerging therapy for the management of hepatocellular carcinoma (HCC). Radioactive Y90 can be loaded onto glass or resin microparticles for intra-arterial selective internal radiation therapy. TARE is a multistage procedure requiring a mapping procedure and a treatment procedure.
Wali Badar +3 more
openaire +1 more source
Modified RECIST criteria after transarterial chemoembolization of hepatocellular carcinoma: CT-pathologic correlation in 178 liver explants [PDF]
, 2011 Aims: To retrospectively evaluate agreement between modified RECIST criteria (mRECIST) assessed at Computed Tomography (CT) and pathology in a large series of patients with hepatocellular carcinoma (HCC) who were transplanted after transarterial ...
PARENTINI, BARBARA
core
Correlation of tumor contrast enhancement on cone-beam CT and tumor response after transarterial radioembolization [PDF]
, 2017 N Kim, A Kim
openalex +1 more source
Evaluation of the pharmacokinetics, dosimetry, and therapeutic efficacy for the α-particle-emitting transarterial radioembolization (αTARE) agent [225Ac]Ac-DOTA-TDA-Lipiodol® against hepatic tumors [PDF]
, 2023 Anders Josefsson +9 more
openalex +1 more source